Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1988-12-6
pubmed:abstractText
A diagnostic test for the detection of Streptococcus pneumoniae meningitis was developed using monoclonal antibodies (MAbs) to phosphocholine (PC) and non-PC determinants of pneumococcal teichoic acids. These MAbs do not recognize other bacteria that commonly cause meningitis. By using a dot blot assay, these MAbs were compared with a polyvalent pneumococcal capsular omniserum and an antiserum made to whole cells for their ability to detect pneumococci in infected spinal fluids. An immunoglobulin M (IgM) anti-PC antibody gave a positive reaction with 16 of 22 (73%) pneumococcal culture-positive spinal fluids. One false-positive result out of 45 pneumococcal culture-negative spinal fluids was also observed. D3114/63, an IgM MAb to non-PC determinants of teichoic acids, detected 15 of 22 of the pneumococcal culture-positive spinal fluids with one false-positive result. IgG2b and IgG3 anti-PC MAbs were less efficient than the IgM anti-PC MAb at detecting pneumococci in spinal fluids. Like the IgM anti-PC MAb, omniserum detected 73% of the culture-positive pneumococcal spinal fluids, with one false-positive result. The use of anti-PC or D3114/63 MAbs instead of a pooled serum such as omniserum has several advantages: (i) use of a single cross-reactive antibody rather than 83 pooled antibodies; (ii) possibility of a higher concentration of reactive antibody, which may increase the sensitivity of the test; (iii) a standardized antibody preparation; (iv) ease of preparation of the antibody; and (v) less expense.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-13301, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-2462151, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-31678, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-3733218, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-3889046, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-3952010, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-3958504, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-4118732, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-4381230, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-6336560, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-6418756, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-6436296, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-67124, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-7020043, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-7231520, http://linkedlifedata.com/resource/pubmed/commentcorrection/2460493-7299349
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1635-40
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.
pubmed:affiliation
Department of Microbiology, University of Alabama, Birmingham 35294.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't